Comparative Pharmacology
Head-to-head clinical analysis: INFUVITE PEDIATRIC PHARMACY BULK PACKAGE versus MVC PLUS.
Peer-Reviewed Evidence
Head-to-head clinical analysis: INFUVITE PEDIATRIC PHARMACY BULK PACKAGE versus MVC PLUS.
INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE) vs MVC PLUS
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
INFUVITE PEDIATRIC is a multivitamin formulation providing essential vitamins for metabolic processes, serving as cofactors in enzymatic reactions (e.g., B vitamins in energy metabolism, vitamin A in vision, vitamin D in calcium homeostasis).
MVC PLUS is a fixed-dose combination of maraviroc, a CCR5 co-receptor antagonist, and lamivudine, a nucleoside reverse transcriptase inhibitor. Maraviroc binds to CCR5 on CD4+ T cells blocking HIV-1 entry; lamivudine inhibits HIV reverse transcriptase via competitive inhibition and chain termination.
Not applicable; INFUVITE PEDIATRIC is indicated for pediatric patients (≤11 years old). For adult use, consider adult multivitamin products.
10 mg orally once daily.
None Documented
None Documented
Variable; thiamine ~18 min, riboflavin ~1.1 h, pyridoxine ~2.5 h, ascorbic acid ~16 d, vitamin A ~18 d (fat-soluble storage).
Terminal elimination half-life: 12-18 hours (mean 14 hours). Clinically, this supports twice-daily dosing with steady-state achieved in ~3 days.
Renal excretion of water-soluble vitamins; fat-soluble vitamins (A, D, E, K) are excreted in bile/feces; minimal unchanged renal elimination.
Renal: ~70% unchanged; Fecal: ~25%; Biliary: <5%
Category C
Category C
Multivitamin
Multivitamin/Mineral Supplement